
07.27.20 (wired.com)
| Moderna’s vaccine candidate heads into final trials, studies show Covid’s effect on the heart, and reopened countries provide guidance on schools. Here’s what you should know:HeadlinesCovid-19 vaccine candidate heads to widespread testing in the USOne of the leading Covid-19 vaccine candidates, made by the biotech company Moderna, will head into its final stage of testing today. Up to 30,000 volunteers will test its effectiveness in preventing the disease, now that it has been shown to be safe in previous trials. Though this is the final stage of testing, the process will likely take months to complete. |